Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization.
about
Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.Iron status in infants with alloimmune haemolytic disease in the first three months of life.Neonatal hemochromatosis: management, outcome, and prevention.Improving the management and outcome in haemolytic disease of the foetus and newborn.
P2860
Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hematological morbidity and ma ...... to red cell alloimmunization.
@ast
Hematological morbidity and ma ...... to red cell alloimmunization.
@en
type
label
Hematological morbidity and ma ...... to red cell alloimmunization.
@ast
Hematological morbidity and ma ...... to red cell alloimmunization.
@en
prefLabel
Hematological morbidity and ma ...... to red cell alloimmunization.
@ast
Hematological morbidity and ma ...... to red cell alloimmunization.
@en
P2093
P1476
Hematological morbidity and ma ...... to red cell alloimmunization.
@en
P2093
Enrico Lopriore
Mirjam E A Rath
Vivianne E H J Smits-Wintjens
P304
P356
10.1016/J.EARLHUMDEV.2011.07.010
P577
2011-07-27T00:00:00Z